Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance sheets

v3.22.1
Consolidated Balance sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 153 $ 576
Restricted cash 135 374
Deferred course expenses 287 304
Prepaid expenses and other current assets 378 607
Inventory 1 1
Discontinued operations current assets
Total current assets 954 1,862
Right-of-use assets 13 20
Other assets 6 6
Discontinued operations-other assets 33 33
Total assets 1,006 1,921
Current liabilities:    
Accounts payable 2,451 2,544
Royalties payable 110 110
Accrued course expenses 246 252
Accrued salaries, wages and benefits 225 202
Operating lease liability, current portion 13 20
Other accrued expenses 2,246 2,114
Deferred revenue 4,370 4,438
Short-term related party debt, net of unamortized debt discount of $133 213 142
Current portion of long term debt, net of unamortized debt discount of $0 1,005 1,011
Discontinued operations-current liabilities 9,699 9,845
Total current liabilities 20,578 20,678
Long-term debt, net of current portion and net of unamortized debt discount of $442 1,958 1,933
Deferred tax liability, net 1,336 1,493
Total liabilities 23,872 24,104
Commitments and contingencies (Note 13)  
Stockholders’ deficit:    
Preferred stock, $0.0001 par value, 20,000,000 shares authorized, none issued
Common stock, $0.0001 par value; 200,000,000 authorized; 33,917,697 shares issued and outstanding as of March 31, 2021 and December 31, 2021 3 3
Additional paid-in capital 13,165 13,161
Cumulative foreign currency translation adjustment 693 837
Accumulated deficit (36,727) (36,184)
Total stockholders’ deficit (22,866) (22,183)
Total liabilities and stockholders’ deficit $ 1,006 $ 1,921